Kim Anh Chu, PHARMD
Pharmacist · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kim Anh Chu’s office at (408) 851-3171 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$183,559
Pharmacies billed $183,559 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 671) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
298 generic and 320 brand-name prescriptions · $183,559 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 158 | $116,939 | $740 |
| Jardiance | 36 | $21,350 | $593 |
| Humulin N | 35 | $6,739 | $193 |
| Humulin R | 30 | $6,285 | $210 |
| Insulin Glargine-Yfgn | 15 | $1,886 | $126 |
See all 16 drugs
| Ozempic | 158 | $116,939 | $740 |
| Jardiance | 36 | $21,350 | $593 |
| Humulin N | 35 | $6,739 | $193 |
| Humulin R | 30 | $6,285 | $210 |
| Insulin Glargine-Yfgn | 15 | $1,886 | $126 |
| Humulin N Kwikpen | 12 | $1,717 | $143 |
| Glipizide Er | 39 | $1,401 | $36 |
| Glipizide | 73 | $1,348 | $18 |
| Metformin Hcl Er | 70 | $650 | $9 |
| Metformin | 41 | $532 | $13 |
| Veo Insulin | 16 | $432 | $27 |
| Ultra-Fine Nano Pen Needle | 13 | $383 | $29 |
| Veo Insulin | 18 | $368 | $20 |
| Pioglitazone | 20 | $233 | $12 |
| Atorvastatin | 18 | $210 | $12 |
| Lisinopril | 11 | $118 | $11 |
Year by year
| 2024 | 671 | 139 | 0% (0) | 48% | $183,559 |
| 2023 | 486 | 106 | 0% (0) | 43% | $115,747 |
| 2022 | 462 | 103 | 0% (0) | 37% | $79,199 |
| 2021 | 475 | 100 | 0% (0) | 36% | $66,519 |
| 2020 | 367 | 103 | 0% (0) | 46% | $52,440 |
| 2019 | 302 | 87 | 0% (0) | 44% | $43,090 |
| 2018 | 328 | 96 | 0% (0) | 44% | $41,369 |
| 2017 | 282 | 98 | 0% (0) | 56% | $44,506 |
| 2016 | 138 | 87 | 0% (0) | None | $12,152 |
| 2015 | 292 | 127 | 0% (0) | 45% | $27,125 |
| 2014 | 231 | 110 | 0% (0) | 43% | $24,701 |
| 2013 | 232 | 107 | 0% (0) | 32% | $16,112 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Ozempic | 56 | $41,281 | $737 |
| Jardiance | 14 | $12,951 | $925 |
| Humulin N | 48 | $8,448 | $176 |
| Humulin R | 26 | $4,353 | $167 |
| Humulin 70-30 | 17 | $4,240 | $249 |
| Humulin N Kwikpen | 14 | $2,903 | $207 |
| Glipizide Er | 23 | $900 | $39 |
| Veo Insulin | 24 | $635 | $26 |
| Glipizide | 48 | $606 | $13 |
| Veo Insulin | 26 | $542 | $21 |
| Pioglitazone | 19 | $542 | $29 |
| Metformin Hcl Er | 40 | $423 | $11 |
| Metformin | 33 | $409 | $12 |
| Ultra-Fine Nano Pen Needle | 13 | $400 | $31 |
2022: 14 drugs
| Jardiance | 15 | $14,240 | $949 |
| Humulin N | 58 | $10,310 | $178 |
| Lantus | 12 | $5,568 | $464 |
| Humulin R | 23 | $3,807 | $166 |
| Humulin N Kwikpen | 17 | $3,656 | $215 |
| Humulin 70-30 | 12 | $2,038 | $170 |
| Glipizide Er | 17 | $921 | $54 |
| Veo Insulin | 40 | $920 | $23 |
| Glipizide | 51 | $654 | $13 |
| Metformin Hcl Er | 49 | $501 | $10 |
| Ultra-Fine Nano Pen Needle | 17 | $484 | $28 |
| Pioglitazone | 11 | $373 | $34 |
| Veo Insulin | 16 | $356 | $22 |
| Metformin | 26 | $348 | $13 |
2021: 12 drugs
| Humulin N | 66 | $12,449 | $189 |
| Lantus | 14 | $6,844 | $489 |
| Humulin R | 27 | $4,867 | $180 |
| Humulin N Kwikpen | 15 | $2,861 | $191 |
| Humulin 70-30 | 14 | $2,566 | $183 |
| Humulin 70/30 Kwikpen | 11 | $2,432 | $221 |
| Glipizide Er | 19 | $1,475 | $78 |
| Veo Insulin | 48 | $1,077 | $22 |
| Glipizide | 52 | $653 | $13 |
| Pioglitazone | 18 | $600 | $33 |
| Metformin | 35 | $458 | $13 |
| Metformin Hcl Er | 39 | $429 | $11 |
2020: 12 drugs
| Humulin N | 71 | $13,547 | $191 |
| Lantus | 12 | $5,250 | $438 |
| Humulin R | 27 | $4,767 | $177 |
| Humalog | 12 | $3,862 | $322 |
| Humulin 70-30 | 13 | $2,710 | $208 |
| Humulin N Kwikpen | 13 | $2,281 | $175 |
| Glipizide Er | 11 | $804 | $73 |
| Glipizide | 49 | $580 | $12 |
| Veo Insulin | 27 | $551 | $20 |
| Pioglitazone | 11 | $378 | $34 |
| Metformin Hcl Er | 21 | $227 | $11 |
| Metformin | 16 | $203 | $13 |
2019: 9 drugs
| Humulin N | 61 | $11,093 | $182 |
| Humulin R | 25 | $4,765 | $191 |
| Humulin 70-30 | 12 | $2,366 | $197 |
| Humulin N Kwikpen | 11 | $1,745 | $159 |
| Glipizide Er | 16 | $1,068 | $67 |
| Glipizide | 42 | $516 | $12 |
| Veo Insulin | 19 | $297 | $16 |
| Metformin Hcl Er | 22 | $222 | $10 |
| Veo Insulin | 14 | $172 | $12 |
2018: 9 drugs
| Humulin N | 55 | $10,816 | $197 |
| Humulin R | 26 | $5,267 | $203 |
| Humulin 70-30 | 11 | $3,429 | $312 |
| Humulin N Kwikpen | 13 | $2,744 | $211 |
| Glipizide Er | 22 | $1,488 | $68 |
| Glipizide | 53 | $870 | $16 |
| Metformin Hcl Er | 31 | $542 | $17 |
| Veo Insulin | 23 | $509 | $22 |
| Metformin | 18 | $207 | $11 |
2017: 6 drugs
| Humulin N | 68 | $12,715 | $187 |
| Humulin N Kwikpen | 14 | $3,069 | $219 |
| Humulin R | 21 | $2,763 | $132 |
| Glipizide | 35 | $498 | $14 |
| Metformin Hcl Er | 19 | $281 | $15 |
| Metformin | 16 | $200 | $12 |
2016: 4 drugs
| Humulin N | 19 | $3,731 | $196 |
| Atorvastatin | 23 | $770 | $33 |
| Metformin | 20 | $250 | $13 |
| Glipizide | 15 | $198 | $13 |
2015: 5 drugs
| Humulin N | 33 | $5,155 | $156 |
| Atorvastatin | 55 | $1,667 | $30 |
| Glipizide | 33 | $441 | $13 |
| Metformin | 18 | $218 | $12 |
| Famotidine | 11 | $192 | $17 |
2014: 4 drugs
| Humulin N | 26 | $3,147 | $121 |
| Atorvastatin | 43 | $1,291 | $30 |
| Omeprazole | 17 | $684 | $40 |
| Glipizide | 14 | $158 | $11 |
2013: 6 drugs
| Atorvastatin | 28 | $1,086 | $39 |
| Pravastatin | 12 | $615 | $51 |
| Simvastatin | 17 | $410 | $24 |
| Metformin | 31 | $365 | $12 |
| Metformin Hcl Er | 15 | $318 | $21 |
| Glipizide | 21 | $317 | $15 |
Professional record
- NPI
- 1801095914
- Licence
- CA 58654
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- 770 E Calaveras Blvd, Milpitas, CA, 95035
- NPI first listed
- 2007-07-17
- NPI last updated
- 2021-11-22
- NPI record certified
- 2021-11-22
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.